There are numerous reasons why contact lenses are beneficial for children, and the safety profile is high. Yet there are still barriers in the mind of the practitioner, parent and young patient to childhood CL wear. Here we address these often cited barriers, with the goal to support your clinical communication on the benefits and safety of contact lenses for kids, to move towards achieving a ‘yes’ from the parent and patient.
If a child is wearing spectacles or using atropine as their primary myopia control treatment, which contact lens should we choose for sports? Is a myopia controlling contact lens needed if it will only be for occasional wear? Here we discuss the options and clinical considerations based on the individual patient.
How does the normal emmetropization process in childhood influence refraction shifts in pseudophakes? Should a myopic shift in a pseudophakic child be viewed as myopia progression? How should they be managed and is myopia control needed? This blog covers important considerations in managing these atypical myopes.
In this review we explore the 6-year results for MiSight 1 day recently presented at the 2020 American Academy of Optometry meeting. Based on the abstract, children who were older at initial fitting (11-15 years) progressed similarly over 3 years to matched children who were treated for 6 years, indicating that older children could still gain a treatment effect from MiSight 1 day.
Refraction can be challenging in children, and even more so in a complex presentation as for this case. Is this patient a myope or not? When dealing with a complex case of pseudomyopia, antimetropia and latent hyperopia, all in one patient – how should we manage the patient? The answer involves balancing goals to manage ametropia correction, binocular vision function and myopia control.
When atropine isn’t working as a monotherapy, is it valuable to combine it with a myopia controlling contact lens? Could switching from atropine to a contact lens be the better option? In this post on the Facebook discussion group, a colleague sought opinions on combining atropine and MiSight contact lenses.